CA3016735A1 - Compositions, devices, and methods of functional dyspepsia sensitivity testing - Google Patents

Compositions, devices, and methods of functional dyspepsia sensitivity testing Download PDF

Info

Publication number
CA3016735A1
CA3016735A1 CA3016735A CA3016735A CA3016735A1 CA 3016735 A1 CA3016735 A1 CA 3016735A1 CA 3016735 A CA3016735 A CA 3016735A CA 3016735 A CA3016735 A CA 3016735A CA 3016735 A1 CA3016735 A1 CA 3016735A1
Authority
CA
Canada
Prior art keywords
value
determined
average discriminatory
food preparations
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3016735A
Other languages
English (en)
French (fr)
Inventor
Zackary IRANI-COHEN
Elisabeth LADERMAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerica Inc
Original Assignee
Biomerica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerica Inc filed Critical Biomerica Inc
Publication of CA3016735A1 publication Critical patent/CA3016735A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Peptides Or Proteins (AREA)
CA3016735A 2016-03-09 2017-03-09 Compositions, devices, and methods of functional dyspepsia sensitivity testing Pending CA3016735A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662305680P 2016-03-09 2016-03-09
US62/305,680 2016-03-09
PCT/US2017/021643 WO2017156313A1 (en) 2016-03-09 2017-03-09 Compositions, devices, and methods of functional dyspepsia sensitivity testing

Publications (1)

Publication Number Publication Date
CA3016735A1 true CA3016735A1 (en) 2017-09-14

Family

ID=59789894

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3016735A Pending CA3016735A1 (en) 2016-03-09 2017-03-09 Compositions, devices, and methods of functional dyspepsia sensitivity testing

Country Status (8)

Country Link
US (2) US20190120835A1 (enExample)
EP (1) EP3427056A4 (enExample)
JP (2) JP2019509485A (enExample)
CN (1) CN109154607A (enExample)
AU (1) AU2017230706A1 (enExample)
CA (1) CA3016735A1 (enExample)
MX (1) MX2018010856A (enExample)
WO (1) WO2017156313A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3145879C (en) 2014-11-14 2025-07-08 Biomerica, Inc. Compositions, devices, and methods of ibs sensitivity testing
WO2017156313A1 (en) * 2016-03-09 2017-09-14 Biomerica, Inc. Compositions, devices, and methods of functional dyspepsia sensitivity testing
EP3497447B1 (en) 2016-07-08 2024-09-04 Biomerica, Inc. Compositions, devices, and methods of depression sensitivity testing

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0310522D0 (en) * 2003-05-08 2003-06-11 Yorktest Lab Ltd Assay panel
US20050255533A1 (en) * 2004-02-10 2005-11-17 Brendan Bioscience, Llc Comprehensive food allergy test
US7601509B2 (en) 2004-07-15 2009-10-13 Power Laura W Biotype diets system: predicting food allergies by blood type
AR057828A1 (es) * 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
WO2007099346A1 (en) * 2006-03-03 2007-09-07 Cambridge Antibody Technology Limited Binding members for ghrelin
US20100227340A1 (en) * 2007-09-10 2010-09-09 Immunohealth International, Llc Method of analysis, detection and correction of food intolerance in humans
WO2010101255A1 (ja) * 2009-03-05 2010-09-10 味の素株式会社 クローン病診断試薬
EP2533052A1 (en) * 2011-06-07 2012-12-12 B.R.A.H.M.S GmbH Diagnostic use of proSomatostatin
JP6198752B2 (ja) * 2012-01-20 2017-09-20 アデレード リサーチ アンド イノベイション ピーティーワイ エルティーディーＡｄｅｌａｉｄｅ Ｒｅｓｅａｒｃｈ ＆ Ｉｎｎｏｖａｔｉｏｎ Ｐｔｙ Ｌｔｄ 胃癌のバイオマーカー及びその使用
EP2657707A1 (en) * 2012-04-26 2013-10-30 B.R.A.H.M.S GmbH Biomakers for the diagnosis, prognosis, assessment and therapy stratification syncope
KR102332418B1 (ko) * 2015-01-30 2021-11-26 사이렉스 래보라토리즈 엘엘씨 다수의 식품 항원들 및 c1q-식품 단백질 면역 복합체에 대한 igg 항체 및 iga 항체의 동시 특징분석
WO2017156313A1 (en) * 2016-03-09 2017-09-14 Biomerica, Inc. Compositions, devices, and methods of functional dyspepsia sensitivity testing

Also Published As

Publication number Publication date
EP3427056A4 (en) 2019-11-06
JP2019509485A (ja) 2019-04-04
JP2022031342A (ja) 2022-02-18
EP3427056A1 (en) 2019-01-16
MX2018010856A (es) 2019-07-10
AU2017230706A1 (en) 2018-09-27
CN109154607A (zh) 2019-01-04
US20260036579A1 (en) 2026-02-05
US20190120835A1 (en) 2019-04-25
WO2017156313A1 (en) 2017-09-14

Similar Documents

Publication Publication Date Title
KR102224649B1 (ko) Ibs 민감도 테스트 구성, 장치 및 방법
JP7176791B2 (ja) うつ病感受性試験の組成物、デバイスおよび方法
US20260036579A1 (en) Compositions, devices, and methods of functional dyspepsia sensitivity testing
JP7689378B2 (ja) 注意欠陥障害／注意欠陥多動性障害（ａｄｄ／ａｄｈｄ）過敏性試験の組成物、デバイスおよび方法
US20260072022A1 (en) Compositions, devices, and methods of migraine headache food sensitivity testing
JP2024060100A (ja) 潰瘍性大腸炎患者における食物感受性の検査キットパネルの作成方法
JP2022022426A (ja) 線維筋痛症感受性試験の組成物、デバイスおよび方法
JP2022125268A (ja) 胃食道逆流性疾患感受性試験の組成物、デバイスおよび方法
EP3394623B1 (en) Compositions, devices, and methods of psoriasis food sensitivity testing
EP4116713A2 (en) Compositions, devices, and methods of osteoarthritis sensitivity testing
US20190170768A1 (en) Compositions, devices, and methods of crohn's disease sensitivity testing

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220308